Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Chemokine CCR8 receptor antagonist R-243 may prevent peritoneal adhesion

May 16, 2011

Clinical study determines pharmacokinetics of oral formulation of antibiotic TP-434

May 16, 2011

First-in-class antimicrobial zempia is active against clinical bacterial isolates

May 16, 2011

New antiviral agent OBR-5-340 is active against coxsackievirus B3 and rhinovirus 5

May 13, 2011

First-in-human data reported on FAB Pharma's antibacterial agent MUT-056399

May 13, 2011

Snapshots: Promising preclinical data on ImmunoGen's anticancer agents IMGN-853 and IMGN-529

May 13, 2011

KAG-308 has beneficial effects in models of chronic colitis

May 12, 2011

Preclinical data disclosed on RDX-5791 for constipation

May 12, 2011

PEM antibiotic POL-7080 well tolerated in phase I study

May 12, 2011

Clinical trial tests effect of food, H2R blockade and vitamin C on GSK-1322322 pharmacokinetics

May 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...